JP2012527487A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527487A5
JP2012527487A5 JP2012512188A JP2012512188A JP2012527487A5 JP 2012527487 A5 JP2012527487 A5 JP 2012527487A5 JP 2012512188 A JP2012512188 A JP 2012512188A JP 2012512188 A JP2012512188 A JP 2012512188A JP 2012527487 A5 JP2012527487 A5 JP 2012527487A5
Authority
JP
Japan
Prior art keywords
trifluoromethyl
compound
group
phenyl
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012512188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012527487A (ja
JP5583758B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2010/073105 external-priority patent/WO2010135972A1/zh
Publication of JP2012527487A publication Critical patent/JP2012527487A/ja
Publication of JP2012527487A5 publication Critical patent/JP2012527487A5/ja
Application granted granted Critical
Publication of JP5583758B2 publication Critical patent/JP5583758B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012512188A 2009-05-25 2010-05-24 1−(置換アリール)−5−トリフルオロメチル−2−(1h)ピリドン化合物及びその塩、並びにその製造方法及びその用途 Expired - Fee Related JP5583758B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200910043501 2009-05-25
CN200910043501.7 2009-05-25
PCT/CN2010/073105 WO2010135972A1 (zh) 2009-05-25 2010-05-24 1-(取代芳基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐的制备方法及其用途

Publications (3)

Publication Number Publication Date
JP2012527487A JP2012527487A (ja) 2012-11-08
JP2012527487A5 true JP2012527487A5 (enExample) 2013-07-11
JP5583758B2 JP5583758B2 (ja) 2014-09-03

Family

ID=43222160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012512188A Expired - Fee Related JP5583758B2 (ja) 2009-05-25 2010-05-24 1−(置換アリール)−5−トリフルオロメチル−2−(1h)ピリドン化合物及びその塩、並びにその製造方法及びその用途

Country Status (7)

Country Link
US (1) US8426407B2 (enExample)
EP (1) EP2436670B1 (enExample)
JP (1) JP5583758B2 (enExample)
KR (1) KR101522924B1 (enExample)
CN (1) CN102149682B (enExample)
AU (1) AU2010252447B2 (enExample)
WO (1) WO2010135972A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008265595B2 (en) 2007-06-20 2014-12-04 PureTech LYT 100 Inc. Substituted N-Aryl pyridinones as fibrotic inhibitors
US9434695B2 (en) 2012-07-18 2016-09-06 Sunshine Lake Pharma Co., Ltd Nitrogenous heterocyclic derivatives and their application in drugs
CN102786467A (zh) * 2012-08-15 2012-11-21 浙江省医学科学院 一种n-取代芳基吡啶酮化合物及其制备方法和应用
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
JP6454348B2 (ja) 2013-12-19 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 窒素複素環誘導体およびその医薬品への応用
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
WO2015171345A1 (en) * 2014-04-30 2015-11-12 Auspex Pharmaceuticals, Inc. N-aryl pyridinones modulators of fibrosis and/or collagen infiltration
CN106466318B (zh) * 2015-08-21 2019-01-01 中南大学 1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用
CN113476447A (zh) * 2021-07-09 2021-10-08 中南大学 一种美氟尼酮在制备急性肝损伤药物中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839346A (en) 1972-12-18 1974-10-01 Affiliated Med Res N-substituted pyridone and general method for preparing pyridones
US4052509A (en) 1972-12-18 1977-10-04 Affiliated Medical Research, Inc. Method for reducing serum uric acid levels
US4042699A (en) 1972-12-18 1977-08-16 Affiliated Medical Research, Inc. Method for reducing serum glucose levels
GB8523126D0 (en) 1985-09-19 1985-10-23 Ici Plc Aryl pyridones
GB8621217D0 (en) 1986-09-03 1986-10-08 Ici Plc Chemical compounds
GB8825314D0 (en) 1988-10-28 1988-11-30 Ici Plc Chemical compounds
GB9006479D0 (en) 1989-04-17 1990-05-23 Ici Plc Novel compounds
US5716632A (en) 1989-11-22 1998-02-10 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
US5518729A (en) 1989-11-22 1996-05-21 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
US5310562A (en) 1989-11-22 1994-05-10 Margolin Solomon B Composition and method for reparation and prevention of fibrotic lesions
US5238906A (en) 1990-11-27 1993-08-24 Sumitomo Chemical Company, Limited Pyridone derivatives and use
DE4343528A1 (de) 1993-12-16 1995-06-22 Schering Ag Zweifach heterocyclisch substituierte Benzole und Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
AP1822A (en) 2002-02-14 2008-01-30 Pharmacia Corp Substituted pyridinones as modulators of P38 MAP kinase.
CN1218942C (zh) * 2002-06-11 2005-09-14 中南大学湘雅医学院 抗纤维化吡啶酮化合物及其生产工艺方法
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
US7825133B2 (en) * 2003-11-14 2010-11-02 Shanghai Genomics, Inc. Derivatives of pyridone and the use of them
DE102004027359A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyridin-2-onverbindungen und deren Verwendung
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
ZA200709593B (en) 2005-05-10 2009-06-24 Intermune Inc Pyridone derivatives for modulating stress-activated protein kinase system
WO2007053610A2 (en) 2005-11-01 2007-05-10 The Regents Of The University Of California Methods of treating atrial fibrillation wtih pirfenidone
US20110034495A1 (en) 2005-11-23 2011-02-10 Intermune, Inc. Method of Modulating Stress-Activated Protein Kinase System
CN101235030A (zh) * 2007-01-30 2008-08-06 中南大学 1-取代-5-三氟甲基-2-(1h)吡啶酮化合物、制备方法及其用途
US20090118135A1 (en) 2007-06-08 2009-05-07 The Burnham Institute Methods and compounds for regulating apoptosis
CN101371833A (zh) 2007-08-23 2009-02-25 中南大学 1-芳基-2(1h)-吡啶酮类化合物在制备治疗皮肤瘙痒药物中的应用
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
EP2389227A4 (en) 2009-01-26 2012-08-08 Intermune Inc METHOD FOR THE TREATMENT OF ACUTE MYOCARDINE CARDS AND ASSOCIATED ILLNESSES THEREOF
WO2010135470A1 (en) 2009-05-19 2010-11-25 Intermune, Inc. Pifenidone derivatives for treating bronchial asthma

Similar Documents

Publication Publication Date Title
RU2451675C2 (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
HRP20151405T1 (hr) Novi supstituirani kinolinski spojevi kao inhibitori reduktaze s-nitrosoglutationa
JP2007519754A5 (enExample)
JP2012236838A5 (enExample)
JP2018522823A5 (enExample)
JP2013505969A5 (enExample)
JP2013537203A5 (enExample)
JP2011519854A5 (enExample)
JP2017537960A5 (enExample)
JP2007508305A5 (enExample)
JP2017533968A5 (enExample)
JP2015517981A5 (enExample)
RU2007132262A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
JP2015531773A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2008517945A5 (enExample)
JP2017504635A5 (enExample)
JP2013531074A5 (enExample)
JP2014526500A5 (enExample)
RU2013138834A (ru) N-[3-(5-амино-3,3а,7,7а-тетрагидро-1н-2,4-диокса-6-аза-инден-7-ил)-фенил]-амиды в качестве ингибиторов васе1 и(или) васе2
JP2014500265A5 (enExample)
JP2013542218A5 (enExample)
JP2008514643A5 (enExample)
JP2010501478A5 (enExample)
RU2009117705A (ru) Производные 2-аминокарбонилпиридина
JP2010505940A5 (enExample)